COVID-19 pill cuts hospitalizations and deaths in half, Merck says


An experimental pill from Merck was shown in a trial to cut the risk of COVID-19 hospitalization and death in half, the company has announced.
The drugmaker said Friday that in a trial, those who received its pill to treat COVID-19, molnupiravir, within five days of experiencing symptoms had half the rate of hospitalization and death as patients who received a placebo, The Associated Press reports. According to Merck, the rate of hospitalizations or deaths was 7.3 percent among those patients who received molnupiravir compared to 14.1 percent for the placebo group.
Merck said it plans to seek emergency use authorization for the pill, which the company noted would become the first oral antiviral medicine to treat COVID-19 if approved. Merck CEO Robert M. Davis said the "compelling results" left the company "optimistic that molnupiravir can become an important medicine as part of the global effort to fight the pandemic." Merck Research Laboratories Vice President Dr. Dean Li also told The Associated Press that the results "exceeded what I thought the drug might be able to do in this clinical trial," adding, "When you see a 50 percent reduction in hospitalization or death that's a substantial clinical impact."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The company says that if approved, it expects to produce 10 million doses of molnupiravir by the end of 2021.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
What does 'conquering' Gaza mean to Israel?
Today's Big Question Benjamin Netanyahu's cabinet has approved a plan to displace much of the Palestinian population while seizing and occupying the territory on a long-term basis.
-
Casey Means: the controversial 'wellness influencer' nominated for surgeon general
In the Spotlight Means has drawn controversy for her closeness to RFK Jr.
-
Trump taps Fox News' Pirro for DC attorney post
speed read The president has named Fox News host Jeanine Pirro to be the top federal prosecutor for Washington, replacing acting US Attorney Ed Martin
-
Sea lion proves animals can keep a beat
speed read A sea lion named Ronan beat a group of college students in a rhythmic dance-off, says new study
-
Humans heal much slower than other mammals
Speed Read Slower healing may have been an evolutionary trade-off when we shed fur for sweat glands
-
Novel 'bone collector' caterpillar wears its prey
Speed Read Hawaiian scientists discover a carnivorous caterpillar that decorates its shell with the body parts of dead insects
-
Scientists find hint of alien life on distant world
Speed Read NASA's James Webb Space Telescope has detected a possible signature of life on planet K2-18b
-
Katy Perry, Gayle King visit space on Bezos rocket
Speed Read Six well-known women went into lower orbit for 11 minutes
-
Scientists map miles of wiring in mouse brain
Speed Read Researchers have created the 'largest and most detailed wiring diagram of a mammalian brain to date,' said Nature
-
Scientists genetically revive extinct 'dire wolves'
Speed Read A 'de-extinction' company has revived the species made popular by HBO's 'Game of Thrones'
-
Dark energy may not doom the universe, data suggests
Speed Read The dark energy pushing the universe apart appears to be weakening